Tokyo, Aug. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058807) titled 'Effect of Alaska Pollack Protein (APP) intake on human skeletal muscle function' on Aug. 20.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This study investigates that APP intake effect of body composition and skeletal muscle function in young adults.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Intake of the APP for 12 weeks.
Interventions/Control_2 - Intake of the whey protein for 12 weeks.
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthy adults
Key exclusion criteria - 1)with severe medical conditions
2)who have participated in other clinical studies, including clinical trials, within the two months prior to the start of this study
3)with food allergies (milk, eggs, wheat, soybeans, pork, chicken, gelatin) or a history of such allergies
4)with implantable devices (cardiac pacemakers, implantable cardioverter-defibrillators, cochlear implants, neurostimulators), cerebral aneurysm clips, magnetic stents, or movable artificial eyes
5)deemed ineligible for participation in this study by the principal investigator
Target Size - 40
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 04 Month 01 Day
Anticipated trial start date - 2025 Year 08 Month 20 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067247
Disclaimer: Curated by HT Syndication.
